Last $94.34 USD
Change Today -0.08 / -0.08%
Volume 617.0K
MJN On Other Exchanges
Symbol
Exchange
New York
As of 8:04 PM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

mead johnson nutrition co (MJN) Snapshot

Open
$94.59
Previous Close
$94.42
Day High
$95.00
Day Low
$94.14
52 Week High
07/22/14 - $98.36
52 Week Low
02/5/14 - $73.23
Market Cap
19.1B
Average Volume 10 Days
716.4K
EPS TTM
$3.55
Shares Outstanding
202.2M
EX-Date
06/19/14
P/E TM
26.6x
Dividend
$1.50
Dividend Yield
1.51%
Current Stock Chart for MEAD JOHNSON NUTRITION CO (MJN)

mead johnson nutrition co (MJN) Details

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children’s nutrition, and other nutritional products. Its infant formula products include formulas for routine feeding; solutions formulas for addressing mild feeding problems, such as gas/fussiness, soy formula, lactose intolerance, anti-regurgitation, and cow’s milk protein allergy risk; and specialty formula products, including formulas for addressing severe intolerance, formulas for premature and low birth weight infants, and medical nutrition products. Its children’s nutrition products comprise products for meeting children’s nutritional needs at one to three years of age, three to five years of age, and beyond five years of age. The company’s children’s nutrition products also include nutritionally-balanced milk supplements for children targeting nutritional needs during specific stages of development; powered milk supplements; and milk modifiers in powder form. It also produces a range of other products, including pre-natal and post-natal nutritional supplements for expectant and nursing mothers. The company markets its products primarily under the Enfamil Premium, Enfamil Premium Newborn, Enfamil A+, Enfalac A+, Enfapro A+, Enfamil Gentlease, Enfapro Premium, SanCor Bebé, SanCor Bebé Premium, Enfamil ProSobee, Enfamil LactoFree, Enfamil AR, Enfamil HA, Enfamil Comfort, Enfamil for Supplementing, Nutramigen, Nutramigen AA, Pregestimil, Enfamil Premature, Enfacare, Enfagrow, Enfagrow A+, Enfagrow Premium, Enfamil Human Milk Fortifier, Sustagen KID, Lactum, Alacta, ChocoMilk, and Cal-C-Tose brand names. It sells its products to mothers, health care professionals, and retailers in approximately 50 countries in North America, Europe, Asia, and Latin America. The company was founded in 1905 and is headquartered in Glenview, Illinois.

mead johnson nutrition co (MJN) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $893.8K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $603.8K
Chief Development Officer and Senior Vice Pre...
Total Annual Compensation: $548.0K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $454.6K
Senior Vice President of Global Supply Chain
Total Annual Compensation: $377.3K
Compensation as of Fiscal Year 2013.

mead johnson nutrition co (MJN) Key Developments

Mead Johnson Nutrition Company Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Revised Earnings Guidance for the Full Year of 2014; Provides Gross Margin Guidance for the Third Quarter, Fourth Quarter and Second Half of 2014

Mead Johnson Nutrition Company announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net sales of $1,111.1 million against $1,055.3 million a year ago. Earnings before interest and income taxes were $244.9 million against $246.8 million a year ago. Earnings before income taxes were $229.6 million against $234.4 million a year ago. Net earnings attributable to shareholders were $171.4 million or $0.84 per diluted share against $172.0 million or $0.84 per diluted share a year ago. On a non-GAAP basis, which excludes specified items, net earnings attributable to shareholders totaled $179.2 million, or $0.88 per diluted share, up 1% from $177.9 million, or $0.87 per diluted share, for the same quarter a year ago. The company reported strong revenue growth and EPS growth impacted by foreign exchange, higher commodity costs and significantly higher advertising and promotion spending associated with key marketing initiatives. For the six months, net sales of $2,224.4 million against $2,093.2 million a year ago. Earnings before interest and income taxes were $536.1 million against $520.3 million a year ago. Earnings before interest and income taxes were $508.4 million against $493.7 million a year ago. Net earnings attributable to shareholders were $373.8 million or $1.84 per diluted share against $360.0 million or $1.77 per diluted share a year ago. Net cash provided by operating activities was $304.0 million against $399.8 million a year ago. Payments for capital expenditures were $94.8 million against $117.0 million a year ago. On a non-GAAP basis, which excludes specified items, net earnings attributable to shareholders totaled $385.3 million, or $1.90 per diluted share, up 8% from $357.8 million, or $1.76 per diluted share, in the first half of 2013. The company revised earnings guidance for the full year of 2014. For the full year, the company now expects GAAP EPS guidance, excluding any further pension MTM adjustments, to be in the range of $3.59 to $3.66 per diluted share, as compared to the previously reported range of $3.54 to $3.66 per diluted share. Non-GAAP EPS, which excludes specified items, is expected to be in the range of $3.65 to $3.72 per diluted share, as compared to the previously reported range of $3.60 to $3.72 per diluted share. The company revised guidance for revenue growth, and now expects constant dollar revenue growth of not less than 9% for the full year of 2014, up from the approximately 8% on which prior guidance was based. The improved outlook for sales growth comes mainly from North America. Based on the gross margin operating expenses assumptions, EBIT margins should approach 24% for the full year consistent with performance in all years, from 2010 onward. On a full-year basis, the company expects that effective tax rate will be near 24%. The company expects gross margins to come in slightly above 62%. Interest expense is expected to be about $60 million. This is slightly higher than prior guidance, as the company moved a bit earlier with the new bond issuance given favorable trends in the market. Capital spending for the full year is expected to remain unchanged at $180 million. Depreciation and amortization expense should be about $90 million. Gross margins in the second half will therefore be at or slightly below the 61.8% recorded in the second quarter. The company expects that gross margins will bottom out in the third quarter at a level slightly below 61.8% before recovering a bit in the fourth quarter. The dipping gross margins in the third quarter are largely from higher start-up costs for the Singapore Spray Dryer. The facility will begin commercial production in August. The company expects to see interest expense grow to about $18 million in the third quarter as the company will have an early call premium on the 2014 notes. Fourth quarter interest expense will be about $14 million and will reflect a full and clean quarter under new debt structure.

Mead Johnson Nutrition Company to Report Q2, 2014 Results on Jul 22, 2014

Mead Johnson Nutrition Company announced that they will report Q2, 2014 results at 8:00 AM, Central Standard Time on Jul 22, 2014

Mead Johnson Nutrition Company, Q2 2014 Earnings Call, Jul 22, 2014

Mead Johnson Nutrition Company, Q2 2014 Earnings Call, Jul 22, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MJN:US $94.34 USD -0.08

MJN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MJN.
View Industry Companies
 

Industry Analysis

MJN

Industry Average

Valuation MJN Industry Range
No financial data is available for MJN.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEAD JOHNSON NUTRITION CO, please visit www.mjn.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.